Post Views: 1,124 Share via: Facebook X (Twitter) LinkedIn More Peter W. PENG View All Posts Post navigation Previous Post SGBCC 2025丨Dr. Giuseppe Curigliano: Cure Outlook for Advanced Breast Cancer Patients — Innovative Therapies and Treatment ChallengesNext PostTrastuzumab and Pertuzumab from QILU PHARMACEUTICAL: A Promising and Reliable Therapeutic Option for Patients with HER2-Positive Breast Cancer